Angiotensin-converting enzyme inhibition alters clusterin mRNA expression in the kidney following renal mass reduction

Pharmacology

Volumn 57, Issue 1, 1998, Pages 13-19

  Olson, Barbara A ^a   Ali, Shujath M ^a   Contino, Lisa C ^a   Brooks, David P ^a   Laping, Nicholas J ^a,b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b SB Pharmaceuticals   (United States)

Author keywords

Apolipoprotein J; Captopril; Sulfated glycoprotein 2

Indexed keywords

CAPTOPRIL; CLUSTERIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; GENE EXPRESSION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT; URINARY EXCRETION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOTTING, NORTHERN; CAPTOPRIL; CLUSTERIN; GENE EXPRESSION; GLYCOPROTEINS; KIDNEY; MALE; MOLECULAR CHAPERONES; NEPHRECTOMY; PEPTIDYL-DIPEPTIDASE A; PROTEINURIA; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TIME FACTORS;

EID: 0031839113     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028221     Document Type: Article

References (29)

1. Wong P, Pineault J, Lakins J, Taillefer D, Leger J, Wang C, Tenniswood M: Genomic organization and expression of the rat TRPM-2 (clusterin) gene, a gene implicated in apoptosis. J Biol Chem 1993;268: 5021-5031.
2. Collard MW, Griswold MD: Biosynthesis and molecular cloning of sulfated glycoprotein 2 secreted by Sertoli cells. Biochemistry 1987;26: 3297-3303.
3. Murphy BF, Kirszbaum L, Walker ID, d'Apice AJF: SP-40,40 a newly identified normal human serum protein found in the SC5b-9 complex of complement and in the immune deposits in glomerulonephritis. J Clin Invest 1988;81:1858-1864.
4. Hartmann K, Rauch J, Urban J, Parczyk K, Diel P, Pilarsky C, Appel D, Haase W, Mann K, Weller A, Koch-Brandt C: Molecular cloning of gp 80, a glycoprotein complex secreted by kidney cells in vitro and in vivo: A link to the reproductive system and to the complement cascade. J Biol Chem 1991;266:9924-9931.
5. Palmer DJ, Christie DL: The primary structure of glycoprotein III from bovine adrenal medullary chromaffin granules: Sequence similarity with human serum protein-40,40 and rat Sertoli cell glycoprotein 2. J Biol Chem 1990;265:6617-6623.
6. May PC, Finch CE: Sulfated glycoprotein 2: New relationships of this multifunctional protein to neurode-generation. Trends Neurosci 1992; 15:391-396.
7. Rosenberg ME, Silkensen J: Clusterin and the kidney. Exp Nephrol 1995;3:9-14.
8. French LE, Chonn A, Ducrest D, Baumann B, Belin D, Wohlwend A, Kiss JZ, Sappino AP, Tschopp J, Schifferli JA: Murine clusterin: Molecular cloning and mRNA localization of a gene associated with epithelial differentiation processes during embryogenesis. J Cell Biol 1993; 122:1119-1130.
9. Schlegel PN, Matthews GJ, Cichon Z, Aulitzky WK, Cheng CY, Chen CL, Saso L, Goldstein M, Janne OA, Bardin CW, Vaughan ED, Jr: Clusterin production in the obstructed rabbit kidney: Correlations with loss of renal function. J Am Soc Nephrol 1992;3:1163-1171.
10. Correa Rotter R, Hosteller TH, Manivel JC, Eddy AA, Rosenberg ME: Intrarenal distribution of clusterin following reduction of renal mass. Kidney Int 1992;41:938-950.
11. Harding MA, Chadwick LJ, Gattone VH, Calvet JP: The SGP-2 gene is developmentally regulated in the mouse kidney and abnormally expressed in collecting duct cysts in polycystic kidney disease. Dev Biol 1991;146:483-490.
12. Brooks DP, De Palma PD, Ruffolo RR Jr: Effect of captopril and the nonpeptide angiotensin II antagonists, SK & F 108566 and EXP3174, on renal function in dogs with a renal artery stenosis. J Pharmacol Exp Ther 1992;263:422-427.
13. Anderson S, Rennke HG, Brenner BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986;77:1993-1999.
14. Hall RL, Wilke WL, Fettman MJ: Captopril slows the progression of chronic renal disease in partially nephrectomized rats. Toxicol Appl Pharmacol 1985;80:517-526
15. Chomczynski P, Sacchi N: Single-step method for RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
16. Laping NJ, Olson BA, Day JR, Brickson BM, Contino LC, Short BG, Ali SM, Brooks DP: The age-related increase in renal clusterin mRNA is accelerated in obese Zucker rats. J Am Soc Nephrol 1998;9: 38-45.
17. Witzgall R, Brown D, Schwarz C, Bonventre JV: Localization of proliferating cell nuclear antigen, vimentin, c-fos, and clusterin in the postischemic kidney: Evidence for a heterogeneous genetic response among nephron segments and a large pool of mitotically active and dedifferentiated cells. J Clin Invest 1994;93:2175-2188.
18. Shimamura T, Morrison AB: A progressive glomerulosclerosis occurring in partial five-sixths nephrectomized rats. Am J Pathol 1975;79: 95-106.
19. Heeg JE, De Jong PE, van der Hem GK, de Zeeuw D: Reduction of proteinuria by angiotensin converting enzyme inhibition. Kidney Int 1987;32:78-83.
20. Yoshida Y, Kawamura T, Ikoma M, Fogo A, Ichikawa I: Effects of antihypertensive drugs on glomerular morphology. Kidney Int 1989;36: 626-635.
21. Yoshida Y, Fogo A, Ichikawa I: Glomerular hemodynamic changes vs. hypertrophy in experimental glomerular sclerosis. Kidney Int 1989; 35:654-660.
22. Choi NH, Nakano Y, Tobe T, Mazda T, Tomita M: Incorporation of SP-40,40 into the soluble membrane attack complex (SMAC, SC5b-9) of complement. Int Immunol 1990;2: 413-417.
23. Jenne DE, Tschopp J: Molecular structure and functional characterization of a human complement cytolysis inhibitor found in blood and seminal plasma: Identity to sulfated glycoprotein 2, a constituent of rat testis fluid. Proc Natl Acad Sci USA 1989;86:7123-7127.
24. Kirszbaum L, Sharpe JA, Murphy B, d'Apice AJ, Classon B, Hudson P, Walker ID: Molecular cloning and characterization of the novel, human complement-associated protein, SP-40,40: A link between the complement and reproductive systems. EMBO J 1989;8:711-718.
25. Vakeva A, Meri S, Lehto T, Laurila P: Activation of the terminal complement cascade in renal infarction. Kidney Int 1995;47:918-926.
26. French LE, Tschopp J, Schifferli JA: Clusterin in renal tissue: Preferential localization with the terminal complement complex and immunoglobulin deposits in glomeruli [see comments]. Clin Exp Immunol 1992;88:389-393.
27. Saunders JR, Aminian A, McRae JL, O'Farrell KA, Adam WR, Murphy BF: Clusterin depletion enhances immune glomerular injury in the isolated perfused kidney. Kidney Int 1994;45:817-827.
28. Aronow BJ, Lund DS, Brown TL, Harmony JAK, Witte DP: Apolipo-protein J expression at fluid-tissue interfaces. Potential role in barrier cytoprotection. Proc Natl Acad Sci USA 1993;90:725-729.
29. Tung PS, Burdzy K, Wong K, Fritz IB: Competition between cell-substratum interactions and cell-cell interactions. J Cell Physiol 1992;152: 410-421.